GeneDx Holdings (WGS) Capital Leases (2020 - 2021)
GeneDx Holdings' (WGS) quarterly Capital Leases came in at $18.4 million in Q4 2021, down 11.31% year-over-year from $20.8 million in Q4 2020, and down 11.31% quarter-over-quarter from $20.8 million in Q4 2020.
Powered by 
Analysis
GeneDx Holdings (WGS) Capital Leases (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Capital Leases for 2 consecutive years, with $18.4 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Capital Leases fell 11.31% year-over-year to $18.4 million in Q4 2021; TTM through Dec 2021 was $18.4 million, a 11.31% decrease from a year earlier, with the FY2021 full-year figure at $18.4 million, down 11.31% from the prior year.
- Capital Leases was $18.4 million for Q4 2021 at GeneDx Holdings, down from $20.8 million in the prior quarter.
- Over five years, Capital Leases peaked at $20.8 million in Q4 2020 and troughed at $18.4 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |